• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Special Reports
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Resources
    • About MassDevice
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
    • In-Depth Coverage
    • Latest News
  • Attend DeviceTalks
    • Events
      • DeviceTalks Minnesota – May 4
      • DeviceTalks Boston – May 27–28
      • DeviceTalks West
      • DeviceTalks Tuesdays
    • DeviceTalks Podcast Network
      • DeviceTalks Weekly
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Advertise
  • Subscribe
Home » Si-Bone prices upsized $108m IPO

Si-Bone prices upsized $108m IPO

October 17, 2018 By Fink Densford

Si-Bone

Si-Bone yesterday priced its initial public offering, which launched today, lifting the total it hopes to bring in from a previous maximum of $103.5 million up to $108 million.

In the offering, the Santa Clara, Calif.-based company said it will offer 7.2 million shares at $15 per share.

Si-Bone had previously said it expected to offer 6.9 million shares at between $13 and $15 per share, which would have brought in between $89.7 million and $103.5 million.

The company said that it listed on the Nasdaq Global Market under the ticker symbol “SIBN,” and that the IPO was set to begin today, according to a press release.

Morgan Stanley and BofA Merrill Lynch are acting as joint book-running managers for the IPO, with Cannaccord Genuity and JMP Securities acting as co-managers.

Si-Bone initially said it was looking to raise approximately $98.7 million in the round when it registered for the IPO in late September.

Filed Under: Business/Financial News, Initial Public Offering (IPO), Wall Street Beat Tagged With: Si-Bone

More recent news

  • FDA warns of Philips ultrasound issues after four patient deaths
  • FDA approves Gore bridging stent graft in complex aortic aneurysms
  • Steris inks $2.1B deal for operating room supplier Xodus Medical
  • Insulet’s Omnipod Discover data platform begins full US rollout
  • Siemens Healthineers exits general ultrasound to focus on cardiac imaging

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >
MDO ad
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2026 · Arrowfly LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy